ondansetron has been researched along with Weight Gain in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Blockade of serotonin (5-HT(3)) receptor signalling in the NTS by either the chronic administration of ondansetron or the genetic inactivation of Tph2 in caudal serotonergic neurons that project to the NTS protects against starvation when AgRP neurons are ablated." | 1.38 | Deciphering a neuronal circuit that mediates appetite. ( Clark, MS; Palmiter, RD; Wu, Q, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Q | 1 |
| Clark, MS | 1 |
| Palmiter, RD | 1 |
1 other study available for ondansetron and Weight Gain
| Article | Year |
|---|---|
Deciphering a neuronal circuit that mediates appetite.
Topics: Agouti-Related Protein; Animals; Appetite; Body Weight; Feeding Behavior; Female; gamma-Aminobutyric | 2012 |